StainExpress™ CD19 CAR T Monitoring Cocktail, human

The StainExpress CD19 CAR T Monitoring Cocktail, human, simplifies and standardizes the characterization of CD19 CAR T cells via flow cytometry. It includes the CD19 CAR FMC63 Idiotype Antibody, REAfinity™, for detecting genetically modified T cells expressing a CAR derived from the anti-human CD19 clone FMC63.

The panel can be customized with additional liquid markers in available channels (e.g., APC) and is optimized to assess the expansion and persistence of CD19 CAR T cells in human peripheral blood for patient monitoring research (not for diagnostic use).

qualityAssuranceSatisfaction
guaranteed
more »
Product data and images for StainExpress™ CD19 CAR T Monitoring Cocktail, human
Figure 1

Examples of immunofluorescent staining with the StainExpress CD19 CAR T Monitoring Cocktail

CAR T cells, generated within 12 days using the CliniMACS Prodigy T Cell Transduction process, were spiked into healthy donor blood samples and were stained with the StainExpress CD19 CAR T Monitoring Cocktail. Staining was carried out at +19 to +25 °C for 10 minutes. Cells were analyzed by flow cytometry using the MACSQuant Analyzer 16. To exclude debris, a gate was set on FSC versus SSC encompassing lymphocytes and monocytes (A). Single cells were identified and doublets excluded by gating on the FSC-A and FSC-H plot, selecting the population with uniform scatter characteristics (B). To exclude residual erythrocytes and to identify leukocytes, CD45 was used to gate on CD45+ leukocytes (C). Dead cells were excluded by gating on 7-AAD−cells (D). CD3+ cells were identified (E) and discriminated in CAR+ and CAR− cells (F). CAR+ cells were further divided into CD4+ and CD8+ T cells (G), as were CAR− cells (H).

Specifications for StainExpress™ CD19 CAR T Monitoring Cocktail, human
Overview

The StainExpress CD19 CAR T Monitoring Cocktail, human, simplifies and standardizes the characterization of CD19 CAR T cells via flow cytometry. It includes the CD19 CAR FMC63 Idiotype Antibody, REAfinity™, for detecting genetically modified T cells expressing a CAR derived from the anti-human CD19 clone FMC63.

The panel can be customized with additional liquid markers in available channels (e.g., APC) and is optimized to assess the expansion and persistence of CD19 CAR T cells in human peripheral blood for patient monitoring research (not for diagnostic use).

Resources for StainExpress™ CD19 CAR T Monitoring Cocktail, human
Documents and Protocols
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?